Drug and Alcohol Treatment Outpatient Clinic

We Care About You And Your Family.

Addiction is not a weakness, it’s a chronic disease. Let’s accept it with love, live with it, and enjoy a free fulfilling life!

Insight Family Practice offers a variety of drug and alcohol treatment and behavioral therapy to help our clients who suffer from mental health disorders, addictions, and other co-occurring disorders. The addiction specialists listen to our clients, they work with you and your loved ones side by side to find a wholeness-tailored solution via evidence-based practice. Our specialists facilitate our clients to develop new tools and skills to change behavior patterns.

Addiction is a chronic disease just like hypertension or diabetes, we have to be mindful in our daily life to achieve a healthier mental and physical state. Our specialists help the clients to recognize their triggers, stop cravings, prevent relapse, and manage recovery for life. Our team is committed to encourage and support our clients in their healing journey, focus on self-love and realization, return to their loved ones and achieve their goals in life. You have the power within you to take responsibilities, make changes in life and achieve a better, more loving and fulfilling life. Let’s make changes together to the better you deserve!



Sublocade (buprenorphine extended-release) injection, is for subcutaneous use for adults with moderate to severe opioid addiction whose withdrawal symptoms are controlled by oral buprenorphine for at least 7 days. It is delivered continuously at a sustained level throughout the month. Sublocade is injected by a treatment provider as a liquid and, once inside the body, turns into a solid gel called a depot (dee-poh). The depot gradually releases buprenorphine at a controlled rate all month.

How does Sublocade block the rewarding effects of opioids?

When the medicine in Sublocade, buprenorphine, attaches to opioid receptors in the brain, other opioids are less likely to attach. While on Sublocade, a person will receive a continuous delivery of buprenorphine all month.

What are the ingredients of Sublocade?

SUBLOCADE contains a medicine called buprenorphine. Buprenorphine is an opioid that can cause serious and life-threatening breathing problems, especially if you take or use certain other medicines or drugs.


Brixadi (buprenorphine) extended-release injection is the ONLY treatment with both monthly and weekly dosing options for moderate to severe opioid use disorder (OUD).

What are the ingredients in BRIXADI?

Active ingredient: buprenorphine

Inactive ingredients:

BRIXADI weekly: anhydrous ethanol and soybean phosphatidylcholine/glycerol dioleate.

monthly: N-methyl pyrrolidine and soybean phosphatidylcholine/glycerol dioleate.



VIVITROL® is a prescription injectable medicine used to:

  • Treat alcohol dependence. You should stop drinking before starting VIVITROL
  • Prevent relapse to opioid dependence, after opioid detoxification


This means that if you take opioids or opioid-containing medicines, you must stop taking them before you start receiving VIVITROL. See “What is the most important information I should know about VIVITROL?”

To be effective, treatment with VIVITROL must be used with other alcohol or drug recovery programs such as counseling. VIVITROL may not work for everyone.

It is not known if VIVITROL is safe and effective in children.

Naltrexone belongs to a class of drugs known as opiate antagonists. It works in the brain to prevent opiate effects (such as feelings of well-being, and pain relief). It also decreases the desire to take opiates.




Suboxone and Subutex

Buprenorphine is used to treat opioid use disorder. Buprenorphine belongs to a class of drugs called mixed opioid agonist-antagonists. It helps prevent withdrawal symptoms caused by stopping other opioids. It is used as part of a complete treatment program for opioid use disorder (such as compliance monitoring, counseling, behavioral contacts, and lifestyle changes).

Suboxone (buprenorphine-naloxone) and Subutex (buprenorphine), both of which were approved by the FDA in 2002, are drugs developed for the treatment of opiate addiction. Before 2000 when the Drug Addiction Treatment Act was passed, the primary medication to treat opiate addictions was methadone. In 2000, however, buprenorphine was approved in the law, and it could be prescribed by physicians who have been trained and certified by the Center for Substance Abuse Treatment to treat opioid addiction.

The main difference is that Suboxone contains both buprenorphine and naloxone, whereas Subutex contains only buprenorphine.








In Crisis? Call or Text 988

SAMHSA’s National Helpline 24/7: 1-800-487-4889